Table 2.
Comparison of cohorts 1 and 2.
| Cohort 1: 1187 patients | Cohort 2: 245 patients | Statistical significance | |||
|---|---|---|---|---|---|
| Age | 59.13 yrs ± 13.9 | 60.1 yrs ± 13.6 | NS | ||
| N | % | N | % | ||
| Male | 547 | 46.1 | 107 | 43.7 | NS |
| Female | 640 | 53.9 | 138 | 56.3 | |
| Adverse features | N | % | N | % | |
| High PP ≥ 50 mmHg | 736 | 62.0 | 161 | 65.7 | NS |
| High DSBP ≥ 135 mmHg | 703 | 59.2 | 146 | 59.6 | NS |
| High DDBP ≥ 85 mmHg | 515 | 43.4 | 101 | 41.2 | NS |
| High NSBP ≥ 120 mmHg | 639 | 54.0 | 138 | 56.3 | NS |
| High NDBP ≥ 75 mmHg | 404 | 34.0 | 83 | 33.9 | NS |
| Absent ND ≤ 10% | 677 | 57.0 | 134 | 54.7 | NS |
| High EM SBP ≥ 140 mmHg | 396 | 33.4 | 74 | 30.2 | NS |
| High MS ≥ 20/15 mmHg | 552 | 46.5 | 106 | 43.3 | NS |
| No. adverse features | N | % | N | % | NS |
| 0 | 63 | 5.3 | 13 | 5.3 | NS |
| 1 | 114 | 9.6 | 22 | 9.0 | NS |
| 2 | 177 | 14.9 | 35 | 14.3 | NS |
| 3 | 168 | 14.2 | 43 | 17.6 | NS |
| 4 | 176 | 14.8 | 35 | 14.3 | NS |
| 5 | 182 | 15.3 | 37 | 15.1 | NS |
| 6 | 151 | 12.7 | 30 | 12.2 | NS |
| 7 | 119 | 10.0 | 23 | 9.4 | NS |
| 8 | 37 | 3.1 | 7 | 2.9 | NS |
| Adverse Features groups | N | % | N | % | |
| 0–2 | 354 | 29.8 | 70 | 28.6 | |
| 3–5 | 526 | 44.3 | 115 | 46.9 | NS |
| 6–8 | 307 | 25.9 | 60 | 24.5 | |
There was no significant difference between the two cohorts.
(Oneway Anova was used for comparing cohort 1 and 2 ages; cross-tabulation with chi-square Test was used to compare adverse features; no. of adverse features and adverse features groups and gender).